Changes in the rate of nicotine metabolism across pregnancy: A longitudinal study

Addiction

Volumn 110, Issue 11, 2015, Pages 1827-1832

  Bowker, Katharine ^a   Lewis, Sarah ^b   Coleman, Tim ^a   Cooper, Sue ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Antenatal; Metabolism; Nicotine; Postpartum; Pregnancy; Smoking

Indexed keywords

COTININE; HYDROXYCOTININE; NICOTINE;

ADULT; ANALOGS AND DERIVATIVES; CHEMISTRY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; LIQUID CHROMATOGRAPHY; LONGITUDINAL STUDY; METABOLISM; MULTILEVEL ANALYSIS; PREGNANCY; PUERPERIUM; SALIVA; SECOND TRIMESTER PREGNANCY; SMOKING; TANDEM MASS SPECTROMETRY; THIRD TRIMESTER PREGNANCY; UNITED KINGDOM; YOUNG ADULT;

ADULT; CHROMATOGRAPHY, LIQUID; COTININE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MULTILEVEL ANALYSIS; NICOTINE; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; SALIVA; SMOKING; TANDEM MASS SPECTROMETRY; UNITED KINGDOM; YOUNG ADULT;

EID: 84944514009     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.13029     Document Type: Article

References (22)

1. Cnattingius S. The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res 2004; 6: S125-40.
2. Berlin I., Grange G., Jacob N., Tanguy M-L. Nicotine patches in pregnant smokers: randomised, placebo controlled, multicentre trial of efficacy. BMJ 2014; 348: g1622.
3. Coleman T., Chamberlain C., Davey M. A., Cooper S. E., Leornardi-Bee J. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2012; 9: CD010078.
4. Dempsey D., Jacob P., Benowitz N. L. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther 2002; 301: 594-8. doi: 10.1124/jpet.301.2.594.
5. Blanchette P., Klein J., Christodouleas J., Kramer M., Koren G. Nicotine metabolism in pregnant smokers measured by segmental hair analysis. Clin Pharmacol Ther 2004; 75: P38.
6. Koren G., Blanchette P., Lubetzky A., Kramer M. Hair nicotine:cotinine metabolic ratio in pregnant women: a new method to study metabolism in late pregnancy. Ther Drug Monit 2008; 30: 246-8.
7. Brajenovic N., Karaconji I. B., Mikolic A., Stasenko S., Piasek M. Tobacco smoke and pregnancy: segmental analysis of nicotine in maternal hair. Arch Environ Occup Health 2013; 68: 117-22.
8. Hukkanen J., Jacob P. III, Benowitz N. L. Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearance. Clin Pharmacol Ther 2006; 80: 522-30.
9. Fagerstrom K. Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. Nicotine Tob Res 2012; 14: 75-8.
10. Benowitz N. L. Biomarkers of environmental tobacco smoke exposure. Environ Health Perspect 1999; 107: 349-55.
11. Bernert J. T., Jacob P. III, Holiday D. B., Benowitz N. L., Sosnoff C. S., Doig M. V. et al. Interlaboratory comparability of serum cotinine measurements at smoker and nonsmoker concentration levels: a round-robin study. Nicotine Tob Res 2009; 11: 1458-66.
12. West O., Hajek P., McRobbie H. Systematic review of the relationship between the 3-hydroxycotinine/cotinine ratio and cigarette dependence. Psychopharmacology (Berl) 2011; 218: 313-22.
13. Levi M., Dempsey D. A., Benowitz N. L., Sheiner L. B. Prediction methods for nicotine clearance using cotinine and 3-hydroxy-cotinine spot saliva samples II. Model application. J Pharmacokinet Pharmacodyn 2007; 34: 23-34.
14. Dempsey D., Tutka P., Jacob P. III, Allen F., Schoedel K., Tyndale R. F. et al. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin Pharmacol Ther 2004; 76: 64-72.
15. Benowitz N. L., Hukkanen J., Jacob P. III. Nicotine chemistry, metabolism, kinetics and biomarkers. Handbk Exp Pharmacol 2009; 192: 29-60.
16. Kim I., Wtsadik A., Choo R. E., Jones H. E., Huestis M. A. Usefulness of salivary trans-3'-hydroxycotinine concentration and trans-3'-hydroxycotinine/cotinine ratio as biomarkers of cigarette smoke in pregnant women. J Anal Toxicol 2005; 29: 689-95.
17. Bland J. M., Altman D. G. Multiple significance tests: the Bonferroni method. BMJ 1995; 310: 170.
18. Berlin I., Gasior M. J., Moolchan E. T. Sex-based and hormonal contraception effects on the metabolism of nicotine among adolescent tobacco-dependent smokers. Nicotine Tob Res 2007; 9: 493-8.
19. Benowitz N. L., Lessov-Schlaggar C. N., Swan G. E., Jacob P. III. Female sex and oral contraceptive use accelerate nicotine metabolism. Clin Pharmacol Ther 2006; 79: 480-8.
20. Dawes M., Chowienczyk P. J. Drugs in pregnancy. Pharmacokinetics in pregnancy. Best Pract Res Clin Obstet Gynaecol 2001; 15: 819-26.
21. Anderson G. D. Pregnancy-induced changes in pharmacokinetics-a mechanistic-based approach. Clin Pharmacokinet 2005; 44: 989-1008.
22. Brose L. S., McEwen A., West R. Association between nicotine replacement therapy use in pregnancy and smoking cessation. Drug Alcohol Depend 2013; 132: 660-64.